Trieste, Italy

Michela Visintin

USPTO Granted Patents = 5 



Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 73(Granted Patents)


Location History:

  • Rome, IT (2009)
  • Trieste, IT (2009 - 2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michela Visintin

Introduction

Michela Visintin is a prominent inventor based in Trieste, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of five patents to her name, her work has the potential to impact various therapeutic areas.

Latest Patents

Michela's latest patents include the "Anti-ADAMTS-5 antibody, derivatives and uses thereof." This invention relates to an antibody that can recognize and bind to an epitope in the spacer domain of ADAMTS-5, along with the nucleic acid and expression vector encoding it, methods of production, and its uses. Another notable patent is the "Anti-TrkA antibodies, derivatives and uses thereof," which focuses on an antibody that recognizes an epitope in the TrkA amino acid sequence, detailing its medical uses and a pharmaceutical composition that includes the antibody or its fragments.

Career Highlights

Throughout her career, Michela has worked with esteemed organizations such as the Medical Research Council and the Scuola Internazionale Superiore Di Studi Avanzati. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific discoveries.

Collaborations

Michela has collaborated with notable colleagues, including Antonino Cattaneo and Gianfranco Caselli. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Michela Visintin's innovative work in the field of biotechnology exemplifies her dedication to advancing medical science through her patents. Her contributions are poised to make a lasting impact on therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…